企业QQ
官方微信
| Viewthisemailinyourbrowser |
| ABBIOTECoffersover 4,000antibodies againstBIOLOGicaltargetsinvestigatedinacademicandpharmaceuticalsinstitutions.Wefocusondeveloping monoclonalandpolyclonalantibodiesthatareunique inbindinganewepitopeorinrecognizinganewtarget.Browseourcatalogforrabbit,mouseandratantibodiesthataredevelopedfor ELISA, westernblot, IHC and flowcytometry applications. 热门抗体示例,点击可查看更多详细信息：CD4(Cat.No.250592) CD8(Cat.No.250596) CD19(Cat.No.250585) CD34(Cat.No.250591) CD31(Cat.No.250590) CD68(Cat.No.250594) IL-10(Cat.No.250713) TNF-alpha(Cat.No.250844) BRCA1(Cat.No.200160) AngiotensinII(Cat.NO.251229) BrdU (Cat.NO.250563) ABBIOTEC isabiotechcompanyfoundedin2007in SanDiego,California,arenownedworld-classLifeSciencesclusterthathostsmorethan1,500researchlabsandbiotechcompanies.Wearefocusedondeveloping,producingandcommercializing nextgenerationantibodies and uniquereagents fortheLifeSciencesresearchcommunityincludingthediagnosticandpharmaceuticalmarkets.ABBIOTECoffers yearsofexpertise makingantibodiesandassaykitsforcatalogproductstothescientificandbiotechcommunity.Withourrecently upgradedanimalfacility,weoffernowlargerscalepolyclonalantibodyproduction madeinUSA. LinkedInWebsiteEmail |